Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Combining brain stimulation with movement therapy to improve arm function after stroke

Official title: Neurophysiological and Behavioral Effects of Combining Transcranial Direct Current Stimulation (tDCS) and Modified-Constraint Induced Movement Therapy (mCIMT) on Upper Limb Function Recovery in Patients with Stroke

Run by King Saud University · NCT06786000 · Data updated 2026-11-12

This study is testing whether adding different types of brain stimulation to movement therapy can help stroke patients improve their arm function better than movement therapy alone.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorKing Saud University
Academic / other
Locations1 site (Riyadh, Riyadh Region)
StatusRecruiting
StartedApril 11, 2023
Main results expectedApril 11, 2025
Study endsApril 11, 2025
Registry record updatedJanuary 22, 2025
Trial IDNCT06786000 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who have experienced a stroke more than three months prior and have unilateral motor deficits.

Probably not a fit

Patients with severe muscle spasticity or contraindications to non-invasive brain stimulation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effects of different types of transcranial direct current stimulation (tDCS) when combined with modified-constraint induced movement therapy (mCIMT) on upper-limb motor function in stroke patients. Participants will be randomly assigned to receive either anodal, cathodal, or bihemispheric tDCS along with mCIMT, or mCIMT alone, over 12 sessions. The study will assess motor recovery through fMRI and TMS before and after the intervention, aiming to determine which tDCS modulation is most effective in enhancing rehabilitation outcomes.

Why it matters

Potential benefit: If successful, this approach could significantly improve upper-limb recovery in stroke patients, enhancing their quality of life.

How similar studies have gone: Previous studies have shown promising results in combining tDCS with rehabilitation therapies, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adult participants clinically diagnosed and confirmed by imaging of ischemic or hemorrhagic cerebrovascular accident (Dahl et al., 2008; Jin et al., 2019).
2. Participant's age older than 18 years (Baltar et al., 2020).
3. Stroke onset more than 3 months with unilateral motor deficits (Lin et al., 2010).
4. Adequate cognitive function is required to follow instructions. The Arabic version of the Mini Mental State Examination (MMSE) should be ≥24 (Kim, 2021).
5. 10° of active extension to the metacarpophalangeal and interphalangeal joints and 20° at wrist will be assessed by manual goniometer (Dahl et al., 2008).
6. Fugl-Meyer assessment (FMA) scores between 19 and 58, indicating moderate to mild impairments.
7. Not participating in other clinical, or research studies at the same time.

Exclusion Criteria:

1. Severe muscle spasticity at the affected limb at all joints (the Modified Ashworth Scale scores \> 3) (Baltar et al., 2020).
2. Contraindications to NIBS (Bornheim et al., 2019).
3. Unilateral neglect (Dahl et al., 2008)
4. Other neurologic or orthopedic conditions that may affect hand function.
5. Unstable medical conditions.

Where it's running

  • King Saud University Medical City
    Riyadh, Riyadh Region, Saudi Arabia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.